Union Budget 2025: 36 life-saving drugs and medicines would be added to the list of medicines fully exempted from basic customs duty.
India Today on MSN5d
Hope comes at a cost: The financial burden of living with breast cancer in IndiaBreast cancer cases and its economic impact are projected to grow substantially in India, with an annual increase of 5.6%.
Study projects rising breast cancer cases in India, with an estimated annual economic burden of $19.55 billion by 2030.
Cancer care in India has made remarkable progress ... and affordable health care solutions to address the high treatment costs. Despite the government's efforts to provide health coverage through ...
India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major ...
Healthcare experts lauded the announcement by Finance Minister Nirmala Sitharaman to setting up daycare cancer centres, ...
Shaw, has introduced Qartemi, India's second CAR-T cell therapy, to treat B-cell Non-Hodgkin Lymphoma. This therapy is priced ...
ThePrint on MSN11d
2nd ‘living drug’ against blood cancer gets regulatory nod. All about Qartemi, made in IndiaTherapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...
Qartemi is a 'living drug' that has been approved by the Central Drugs Standard Control Organisation (CDSCO) for blood cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback